What’s The Buzz About Curaleaf Listing On The TSX?

In this episode of the Trade To Black Podcast, we’re taking a closer look at the stock market. As we embark on a journey through the ever-evolving landscape of stock listings, we shine a spotlight on Curaleaf (CNSX: CURA) gearing up for a prospective TSX listing. They recently filed an application to list subordinate voting shares there.

If they successfully uplist, they’ll be joining TerrAscend in a coveted spot, possibly attracting new institutional investment for the company, and certainly gaining more visibility. Does Curaleaf applying to uplist on the TSX hint at a monumental shift looming on the horizon?

We talk about the intricate dynamics of companies striving for stock exchange listings, with Curaleaf leading the charge, and the profound impact of rescheduling reforms, demystifying the rapidly transforming market landscape. What does the future hold for other cannabis company listings and volatility reduction? We’ll share our thoughts.

Catch up on what trends are currently going on in the world of canna. Why are companies are flocking to US exchanges in pursuit of success? We’ll take a closer look at some of the recent political tide swells that might impact the momentum of cannabis legislative changes.

There’s a groundbreaking pharmacy rule in Georgia that’s revolutionizing access to medicinal products. Could this be a game-changing moment? It could potentially have a ripple effect across states. We will examine industry risks and explore the role of industry titans like Big Pharma. Plus, we take a closer look at the performance of key industry players, including the standout GTI.

Don’t forget to hit that like button on our YouTube so you can subscribe to stay informed on developing news in emerging industries.

You might also like

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More